Taejoon completed to construct FDA standardized cGMP plant.

Published: 2005-10-27 06:59:00

Updated: 2005-10-27 06:59:00

Taejoon Pharm. Co. announced that the 2nd cGMP plant was finished to construct in conformance to the U. S. FDA standards as one of the company's mid and long term projects titled "Vision 2010", having high tech automated facilities and infrastructures for the quality upgrade of pharmaceutical pro...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK